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Abstract The BMP/Smad signaling pathway plays an impor-
tant role in the viability and differentiation of osteoblast;
however, it is not clear whether this pathway is involved in
the fluoride-induced osteoblast differentiation. In this study,
we investigated the role of BMP/Smad signaling pathway in
fluoride-induced osteoblast-like Saos-2 cells differentiation.
Cells were exposed to fluoride of different concentrations (0,
0.1, 0.2, 0.4, 0.8, and 1.6 mM), and cell proliferation was
determined using WST assays. The expression of osteoblast
marker genes such as osteocalcin (BGP) and bone alkaline
phosphatase (BALP) were detected by qRT-PCR. We found
that fluoride enhanced the proliferation of Saos-2 cells in a
dose-dependent manner and 0.2 mM of fluoride resulted in a
higher expression of osteoblast marker genes. In addition,
immunofluorescence analysis showed that the promotion ef-
fects of 0.2 mM of fluoride on Saos-2 cells differentiation
were associated with the activation of the BMP/Smad path-
way. Expression of phosphorylated Smad1/5(p-Smad1/5) was
higher in cells exposed to 0.2 mM of fluoride. Plasmid
expression vectors encoding the short hairpin RNA
(shRNA) targeting Smad4 gene were used to block the
BMP/Smad pathway, which resulted in a significantly reduced
expression of BGP and BALP as well as their corresponding
mRNA. The mRNA levels after transfection remained low
even in the presence of fluoride. The present results reveal that
BMP/Smad signaling pathway was altered during the period
of osteogenesis, and that the activities of p-Smad1/5 were
required for Saos-2 cells viability and differentiation induced
by fluoride.
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Introduction
Fluoride is a commonmineral found in soil, water, and various
foods. As excessive and prolonged intake of fluoride can
cause diseases such as dental fluorosis, skeletal fluorosis,
and the weakening of bones, low doses of fluoride have been
shown to reduce tooth decay and improve oral health without
health risks. The action of fluoride on bone has been studied
extensively, and the effects of fluoride on the physical prop-
erties of bone are well documented. As the dose of fluoride is
certainly a factor in affecting bone quality and growth, recent
studies have looked at how fluoride affects the bone signaling
pathway, leading to changes in the bone [1–3].
The formation of bone and the development of the skeletal
system require the coordinated activities of multiple signaling
proteins, such as bone morphogenetic proteins (BMPs). BMPs
belong to the biggest member of the transforming growth factor
beta (TGF-β) family of growth and differentiation factors [4].
Like other members of the TGF-β superfamily, BMPs exert
their biological functions via interaction with two different
types of serine/threonine kinase receptors-termed types I and
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II. Signals from the type I receptor, when phosphorylated by the
type II receptor, are transmitted to the downstream substrates
through various molecules, the most important among them
being Drosophila mothers against decapentaplegic protein
(Smads). Subsequent activation of target genes by Smads sig-
naling is essential for bone development.
Smads are classified into three subgroups according to their
functions: (1) pathway-restricted Smads (R-Smads: Smad1,
Smad2, Smad3, Smad5, Smad8, and Smad9). (2) Common
partner Smads (Co-Smad: Smad4) that provide R-Smads with
DNA binding properties. (3) Inhibitory Smads (I-Smads:
Smad6 and Smad7) [5]. Upon the stimulation of BMPs ligand,
R-Smads are phosphorylated by the serine/threonine kinase of
the type I receptor and forms a heteromeric complex with the
Co-Smad, Smad4. The complex is then translocated into the
nucleus to regulate the transcription of target genes in con-
junction with other nuclear cofactors, such as osteocalcin
(BGP) and bone alkaline phosphatase (BALP). BGP and
BALP are marker genes of cell viability and differentiation
of osteoblast. I-Smads interfere with the type I receptor acti-
vation of R-Smads, thus hindering the assembly of R-Smads
with Co-Smad. Although the downstream signaling of the
BMP-2/Smad pathway leading to osteoblast differentiation
has been extensively investigated, the changes of Smads
remain poorly understood.
Human osteosarcoma Saos-2 cells have been shown to
contain extractable bone-inducing agents that possess osteo-
blastic properties known for inducing differentiation [6, 7].
Recent findings from molecular studies suggest that BMPs
differ from other osteogenic compounds. Many signaling
pathways with diverse functions have been found to play a
role in BMP/Smads-mediated osteogenesis. Several of these
pathways are also critical in the differentiation of other cell
lineages, including chondrocytes and osteoblasts. Although
fluoride has been known to affect bone cells, relatively little is
known about the specific mechanisms responsible for these
effects. This study aims to summarize our current knowledge
of BMP/Smads-mediated osteogenesis by presenting recently
completed work which may help us to further elucidate the
mechanisms of fluoride-induced Saos-2 cells differentiation.
Materials and Methods
Cell Culture and Conditioned Medium
The human osteoblast-like cell line (Saos-2) was obtained
from the American Type Culture Collection, derived from a
human osteosarcoma [8, 9]. The cell line used in the study
were maintained in IMDM and RPMI-1640 (Hyclone Labo-
ratories, Beijing, China) medium supplemented with 10 %
fetal bovine serum and penicillin/streptomycin mixture (100
U/mL penicillin G, 100 μg/mL streptomycin sulfate; Hyclone
Laboratories, Beijing, China) at 37 °C in a humidified atmo-
sphere of 95% air and 5%CO2. After a 36-h attachment, cells
were grown to 80% confluence, and the mediumwas replaced
with serum-free medium and then various doses of NaF were
added.
Cell Proliferation
Saos-2 cells were seeded into 96-well flat-bottomed plates at a
density of 5×103 cells/well, and then incubated with 0, 0.1, 0.2,
0.4, 0.8, and 1.6 mM NaF for 24, 48, and 72 h. Cell prolifer-
ation was determined using WST-8 dye (Cell Counting Kit-8/
CCK-8, Beyotime, Jiangsu, China) according to manufac-
turer’s instructions. After 10 μLWST-8 dye was added to each
well, cells were incubated at 37 °C for 2 h and the absorbance
was measured at 450 nm using a microplate reader (Bio-Rad,
Hercules, USA). The experiment was repeated six times, and
the mean value was calculated for each NaF concentration.
Quantitative Real-Time PCR
Saos-2 cells were exposed to NaF, and total RNAwas isolated
using a Fast Pure RNAKit (Takara Bio, Shiga, Japan) according
to the manufacturer’s instructions. For reverse transcription reac-
tion, cDNA was synthesized from total RNA (1.0 μg/reaction)
using Reverse Transcription kit (Promega, Madison, USA) at
42 °C for 60 min and then 95 °C for 10 min. Quantitative real-
time PCR (Q-PCR) was performed in a total reaction volume of
20 μL with an Real Master Mix (SYBR Green) kit (Tiangen
Biotech, Beijing, China) per well using 1.0 μL of cDNA tem-
plate and the appropriate primer for the target genes and normal-
ized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
The primer sequences and annealing temperatures are shown
in Table 1. Q-PCR amplifications were performed in a capped
8-well optical plate. The reaction conditions were as follows:
2 min at 95 °C, 40 cycles of 20 s at 95 °C, and 10 s at 68 °C.
Fluorescence of the gene specific Q-PCR products was continu-
ously measured and used for quantitative purposes. At the end of
the amplification period, melting curve analysis was performed
to confirm the specificity of the amplicon. Relative quantification
of gene expression was calculated by using 2−ΔΔCT equation. All
data derived using Q-PCR was from multiple experiments with
at least triplicate independent biological samples.
Immunofluorescence
The cells exposed to NaF for 72 h were fixed with 4 %
paraformaldehyde for 30 min. They were then permeabilized
in PBS/0.2 % Triton X-100 for 10 min and blocked with 3 %
bovine serum albumin in PBS for 30 min. The cells were then
incubated with primary antibodies overnight. Mouse mono-
clonal anti-Smad1 antibody (Abcam, Cambridge, UK) and
phosphorylated rabbit polyclonal anti-Smad1/5 antibody (Cell
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Signaling Technology Inc., Danvers, USA) mixed together
were used at 1:50, Mouse monoclonal anti-Smad5 antibody
(Abcam, Cambridge, UK) and phosphorylated rabbit polyclon-
al anti-Smad1/5 antibody(Cell Signaling Technology Inc., Dan-
vers, USA) mixed together was used at 1:50, rabbit polyclonal
anti-Smad4 antibody (Cell Signaling Technology Inc., Danvers,
USA) was used at 1:50. Cells were washed three times in PBS
and then stained with the mixed secondary antibodies for
60 min. DayLight 405-conjugated goat anti mouse antibody
(1:100; EarthOx Biotech Inc., San Francisco, USA) and Cy3-
conjugated goat anti rabbit antibody (1:200; Beyotime, Jiangsu,
China) were mixed together. FITC-conjugated goat anti rabbit
antibody (Boster Biotech Inc.,Wuhan, China) was used at 1:60.
The expression and locations of Smads in Saos-2 cells were
observed using a C1 plus (Nikon Corp., Tokyo, Japan) lasers
scanning confocal microscope and processed using Adobe
Photoshop.
ShRNA and Transfection
Four pairs of green fluorescent protein (GFP)-labeled shRNA
targeting Smad4 corresponding to the respective coding
regions were designed and synthesized by custom-made plas-
mid vectors (GenePharma Corp., Shanghai, China) and used
according to the manufacturer’s protocols. The nonsense se-
quence with no similar match to any known sequence was used
as control. The Smad4-shRNA1 sequence: CTGCCAACTTT
CCCAACAT; the Smad4-shRNA2 sequence: GCCTCCCATT
TCCAATCAT; the Smad4-shRNA3 sequence: CGGTCTTTG
TACAGAGTTA), and the nonsense sequence to Smad4 was
named negative control shRNA (NC-shRNA: GGTGTGCAG
TTGGAATGTA). All shRNA sequences were compared against
human sequences deposited in GenBank™ databases with
BLAST (Basic Local Alignment Search Tool) searches using
the NCBI (National Center for Biotechnology Information)
tools. Plasmid stocks were titrated by infection in Saos-2 cells
and assessed by GFP fluorescence. For shRNA experiments,
Saos-2 cells were grown overnight in 6-well plates. Cells were
transfected with 20 ng/ul of shRNA using X-tremeGENE HP
DNA™ (Roche Diagnostics GmbH,Mannheim, Germany) as
instructed by the manufacturer. After transfection, Smad4
suppression was analyzed by Q-PCR to confirm gene knock-
down. Treatment with fluoride, the expression of BGP and
BALP were determined after Smad4-shRNA transfection.
Table 1 RT-qPCR primers for
gene expression analysis Primer GenBank accession no. Sequence(5′-3′) Annealing temperature (°C)
BALP NM_000478.4 F:CATCCTGTATGGCAATGGG 56
R:CATCCTGTATGGCAATGGG
BGP NM_199173.3 F:AGGGCAGCGAGGTAGTGA 57
R:CCTGAAAGCCGATGTGGT
Smad4 NM_005359.5 F:CCATCATAACAGCACTACC 55
R:CGTATCCATCAACAGTAACA
GAPDH NM_002046.3 F:GGATTTGGTCGTATTGGG 56
R:GGAAGATGGTGATGGGATT
Fig. 1 Growth curve of fluoride-
treated Saos-2 cells. Saos-2 cells
were seeded into 96-well plates
and cultured with different
concentrations of NaF for 24, 48,
and 72 h as indicated in the
“Materials and Methods.” The
WST assay was performed to
quantify the cytotoxicity of
fluoride to Saos-2 cells. Asterisk
indicate the significant
differences
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Statistical Analysis
Results were presented as means±SEM. Each value represents
the mean of at least three repetitive experiments in each group.
ANOVAwas used to analyze groups with more than two sets
of data, and Student–Newman–Keuls post hoc analysis was
used to compare groups of data. T test was used to compare the
effect of the compounds and their difference from the untreated
control. All statistical calculations were processed using the
SPSS 13.0 (SPSS Inc., Chicago, IL, USA) software. Values of
P<0.05 were considered significant.
Results
As shown in Fig. 1, the survival rates of Saos-2 cell increased
as fluoride concentration increased at both 48 and 72 h post-
treatment with fluoride, except at 1.6 mM. Moreover, Saos-2
Fig. 2 Quantitative RT-PCR
results of BALP and BGP mRNA
in fluoride-treated Saos-2 cells.
Saos-2 cells were treated with
NaF over 72 h and subjected to
real-time RT-PCR analysis using
specific primers. Expression was
quantified by the 2-ΔΔCT
method. Gene expression was
determined in triplicate,
normalized with GAPDH, and is
graphed relative to expression.
*P<0.05, compared with the
control group
Fig. 3 Content of Smad1 and
p-Smad1/5 protein in fluoride-
treated Saos-2 cells. Laser
scanning confocal microscopy
was used to detect expression of
Smad1 and p-Smad1/5 proteins
after exposure to NaF (200×). a, c
Control (0 mM NaF) and b, d
0.2 mM NaF groups; a, b Smad1
and c, d p-Smad1/5. Three wells
were assayed for each
experimental treatment, and three
separate experiments were
performed
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cells with 0.2 mM fluoride over 72 h exhibited significantly
higher level of proliferation comparedwith other concentrations.
Thus, fluoride-induced Saos-2 cell osteoblast marker genes
expression was examined at the concentration of 0.2 mM fluo-
ride for 72 h.
Subsequently, we found that treatment with fluoride en-
hanced the expression of BGP and BALP, the early markers of
osteoblast differentiation, compared with the control group
(Fig. 2). These results demonstrate that fluoride at a dose of
0.2 mM promotes the osteoblastic differentiation of Saos-2
cells.
We further found that Smad1, Smad5, and p-Smad1/5 were
present in the cytoplasm and nucleus of Saos-2 cells (Figs. 3
and 4), and Smad4 exhibited that nuclear accumulation upon
stimulation with 0.2 mM fluoride, compared with the control
group (0 mM NaF) (Fig. 5). Upon NaF stimulation, both R-
Smads accumulated in the cytoplasm and nucleus of Saos-2
cells (Figs. 3b and 4b), which was not significantly elevated
compared with the control group (Figs. 3a and 4a). Likewise,
Smad4 was not significantly changed after stimulation by
0.2 mM fluoride (Fig. 5b). Therefore, fluoride did not signif-
icantly change the protein level of total R-Smads and Co-
Smad, but the levels of R-Smad phosphorylation significantly
increased (Figs. 3c, d and 4c, d).
Finally, we detected if Smad4 silencing abrogates fluoride-
induced Saos-2 cells differentiation, shRNAs were designed to
target on the human Smad4 mRNA (Fig. 6a). The RNAi
efficiency in Saos-2 cells was evaluated by RT-qPCR. The
Smad4 shRNA1, shRNA2, and shRNA3, which targeted dif-
ferent Smad4 cDNA sequences respectively, reduced the levels
of Smad4 mRNA expression, with shRNA3 being more effec-
tive than others (Fig. 6b), but the expression of Smad4 was not
Fig. 4 Content of Smad5 and p-
Smad1/5 protein in fluoride-
treated Saos-2 cells. Laser
scanning confocal microscopy
was used to detect expression of
Smad5 and p-Smad1/5 proteins
after exposure to NaF(200×). a, c
Control (0 mM NaF) and b, d
0.2 mM NaF groups; a, b Smad5
and c, d p-Smad1/5. Three wells
were assayed for each
experimental treatment, and three
separate experiments were
performed
Fig. 5 Content of Smad4 protein in fluoride-treated Saos-2 cells. Laser
scanning confocal microscopy was used to detect expression of Smad4
proteins after exposure to NaF (200×). a Control (0 mM NaF) and b
0.2 mM NaF groups. Three wells were assayed for each experimental
treatment, and three separate experiments were performed
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remarkably suppressed by mismatch shRNA interference at
the mRNA level (Fig. 6b). Given that the RNAi effect by
shRNA3 was found to be the most reproducible, shRNA3
was used for the subsequent RNAi experiments. As shown in
Fig. 7, treatment with fluoride enhanced the expression of BGP
and BALP compared with the control group, whereas blocking
BMP/Smad signaling inhibited the upregulated expression of
BGP and BALP induced by fluoride, suggesting that inhibition
of the BMP/Smad signaling interrupts fluoride-induced Saos-2
cells differentiation.
Fig. 6 Effects of shRNAs against
Smad4 mRNA. a Transfection
efficiency of Smad4-shRNA
observed by laser scanning
confocal microscopy (200×); b
quantitative RT-PCR showing
expression of Smad4 mRNA in
Saos-2 cells following infection
with shRNA1,2,3 and mismatch
shRNA. Gene expression was
determined in triplicate,
normalized with GAPDH and is
graphed relative to expression.
*P<0.05, compared with the
control group




was determined by quantitative
RT-PCR, normalized to GAPDH
expression, and is graphed
relative to the expression.
*P<0.05, compared with the
control group; #P<0.05,
compared with the group only
treated with fluoride
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Discussion
BMP signaling plays a significant role in osteoblast differen-
tiation. However, how BMP/Smads signaling drive transdif-
ferentiation for osteoblasts differentiation remains unclear. In
this study, we found that fluoride significantly enhanced the
proliferation of Saos-2 cells, which is consistent with the find-
ings of Lau and Baylink [10], that BMP/Smad signaling be-
comes activated in Saos-2 cells during their differentiation, and
that the activation of Smads during Saos-2 cells differentiation
was due to phosphorylation of R-Smads, rather than enhance-
ment in total R-Smads and Co-Smad.
Emerging evidence indicates that fluoride acts directly on
cells of the osteoblast lineage to promote their development
and/or activity. Okamoto et al. showed that increased BMP4
signaling in vivo stimulated osteoblast [11]. Chen et al.
showed that a peak expression for type I collagen occurred
in the early phase (day 1) of fetal rat calvarial osteoblasts [12].
BGP is the most abundant noncollagenous protein in bone
and is present in the bone matrix and synthesized by osteo-
blasts [13, 14]. Van Straalen et al. showed that bone-alkaline
phosphatase is a useful parameter for monitoring changes in
bone formation [15]. Accumulation of these bioactive mole-
cules in vitro could potentially induce proliferation and dif-
ferentiation of osteoblasts and result in the formation of new
bone [16]. In our present study of Saos-2 cells, the expression
of twomarkers for osteoblastic differentiation—BGP andBALP
mRNAs—were significantly increased by fluoride. The expres-
sion of BALP and BGP were higher in the fluoride group than
the control group. However, the expression of BGP was not
significantly increased as the expression of BALP (Fig. 2). This
led us to assume that BALP is more sensitive in monitoring
osteoblast-like Saos-2 cells formation and differentiation.
BMP signals through the type II receptor, encoded by differ-
ent genes in combination with the type I receptors [17–19]. The
type I receptors, BMP-RIA and BMP-RIB, have been shown to
stimulate osteoblastic differentiation in preosteoblastic cell lines
[20]. Some scholars indicated that C2C12 myoblasts can be
induced to express some early osteoblast markers in response to
elevated BMP signaling [21, 22]; however, this stimulation was
inadequate for osteoblast differentiation. BMPs form a unique
group of proteins within the transforming growth factor-β
super-family and have a pivotal role in the regulation of bone
induction, maintenance and repair [23, 24]. BMPs stimulate the
activation of Smad proteins that accumulate in the nucleus and
control the transcription of a large number of target genes.
Smad1, Smad5, and Smad8 are recognized by BMP type I
receptor, which play important roles in osteoblast differentiation
[24]. Smad1 and Smad5 have been shown to be the major
signaling molecules for inducing differentiation of C2C12 cells
into osteoblasts [25]. Several studies have shown that Smad1/5/
8 could form heteromeric complexes with Co-Smad Smad4 and
translocate into the nucleus where they regulate transcription of
various target genes [26]. In our study, we found that phosphor-
ylations of Smad1/5 are equally enhanced in fluoride-treated
Saos-2 cells; however, there is very little difference between
fluoride-treated and control cultures in total Smad1 and Smad5,
which demonstrates that an activation of fluoride-induced Saos-
2 cells differentiation was due to dephosphorylation of Smad1
and Smad5, rather than enhanced expression of total Smad1
and Smad5. The role of Smad4 in the phases of osteoblast-
differentiating process remains unclear. In the present study,
fluoride had no effect on the protein level of Smad4. It is
possible that partially functional Smad4 interacted with
phosphorylationed Smad1/5 to form hetero-oligomeric com-
plexes which translocate into the nucleus to regulate the tran-
scription of various target genes, as the total level of Smad4
have not significantly change.
Taken together, we demonstrated that fluoride induces Saos-
2 cells differentiation in parallel with the phosphorylations of
Smad1/5, which then mediated differentiation via activation of
Smad signaling. We therefore conclude that the BMP/Smad
pathway plays a role in fluoride-induced differentiation of
Saos-2 cells.
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